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I 
N the last ten years, an avalanche of new information has 
flattened much of the conceptual framework erected in 
the first three decades of cytokine research. This article 
briefly reviews the concepts that collapsed, then attempts to 
begin replacing them. We see cytokines as specialized sym- 
bols in a language of intercellular communication, whose 
meaning is controlled by context (Sporn and Roberts, 1988, 
1990; Nathan, 1990; Kenyon and Kamb, 1989). To illustrate 
control by context, we summarize new evidence that the re- 
sponse of cells to cytokines can be markedly affected by the 
extracellular matrix in which most cells are normally em- 
bedded. 
Legacy: Concepts Crushed by Complexity 
Immunologists often date the start of the cytokine era from 
the description of lymphocyte-derived mediators or "lym- 
phokines" (Dumonde et al., 1969) in the late 1960s (David, 
1966~ Bloom and Bennett,  1966).  However,  the roots go 
much farther back. Nerve growth factor was discovered in 
1951  (Levi-Montalcini and  Hamburger),  and  interferon, 
whose relevance to immunology is indisputable, was discov- 
ered in 1954 (Nagano and Kojima). As this illustrates, until 
recently, investigators in each of four different areas- immu- 
nology  (interleukins),  virology (interferons),  hematology 
(colony-stimulating  factors), and cell biology (peptide growth 
factors)-have worked in relative isolation from parallel de- 
velopments in the other areas. In this article, we will refer 
to all of the above polypeptide regulatory factors as "cyto- 
kines" (Bigazzi et al., 1975),  an enlarged term that took root 
in immunologic parlance as the perception spread that inter- 
ferons, colony-stimulating factors (CSFs),~ and growth fac- 
tors play a central role in immunology (see Table I). None- 
theless, the persistent legacy of the historical isolation is a 
terminology imbued with defunct assumptions, notably that 
a cytokine functions largely within the category in which it 
came to light; arises chiefly from one type of cell; has a prin- 
cipal action reflected in its name; can be categorized as either 
a stimulator or an inhibitor; and has a set of additional ac- 
tions that are related to each other in some obvious way. 
By the standards of those concepts, cytokine research is 
1. Abbreviations  used in this paper:  CSF, colony-stimulating  factor; GM, 
granulocyte-macrophage; TGF, transforming growth factor; TNE  tumor 
necrosis factor. 
in chaos.  Most cytoldnes arise from seemingly unrelated 
types of cells. Most have bioactivities so diverse as to seem 
unrelated; these usually include the ability both to promote 
and inhibit cellular proliferation and differentiation. Most 
activities manifest by a  given cytokine can be exerted by 
others. Many cytokines  that subserve familiar functions post- 
nataUy play different or  unknown roles  embryologically. 
Given the amino acid sequence of a cytokine and any of its 
actions, we cannot predict when or where it will do what 
else. This last point is an operational definition of the inade- 
quacy of current concepts. 
Meaning in Context: Messages  from Matrix 
We define a cytokine as a soluble (glyco)protein, nonimmu- 
noglobulin in naiure,  released by living cells of the host, 
which acts nonenzymatically  in picomolar to nanomolar con- 
centrations to regulate host cell function. Cytokines make up 
the fourth major class of soluble intercellular signaling mole- 
cules, alongside neurotransmitters, endocrine hormones, and 
autacoids.  The physiologic importance of cytokines is  no 
less than that of the other classes. 
We suggest that a central role of cytokines is to control the 
(re)modeling of tissues, be it developmentally programmed, 
constitutive,  or unscheduled.  Unscheduled remodeling is 
that which accompanies inflammation, infection, wounding, 
and repair (Vlassara et al., 1988). In the immune system, the 
relevant tissues are not just those within fixed organs like 
lymph  nodes, thymus, marrow, and spleen, but also the transi- 
ent  cell  assemblages that can infiltrate any organ that is 
wounded, infected, or inflamed. From this perspective, it is 
not surprising that a given tissue may exert a profound influ- 
ence on how cells within it respond to cytokines. Recent evi- 
dence documents at least seven types of interaction between 
cytokines and cell matrix. 
Adherence to Matrix Induces Cells to Make Cytokines 
This has been clearly demonstrated with monocytes  and mac- 
rophages. Adherence to fibronectin induces transcription of 
granulocyte-macrophage (GM)-CSF (Thorens et al., 1987), 
and CSF-1 (Eierman et al., 1989); adherence to collagen in- 
duces IL-1 (Dayer et al., 1986) and TNF-ot (Eierman et al., 
1989); interaction with proteins (postulated to include matrix 
proteins) that have been modified with advanced glycosyla- 
© The Rockefeller University Press,  0021-9525/91/06/981/6  $2.00 
The Journal of Cell Biology, Volume 113, Number 5, June 1991 981-986  981 Table L Cytokines Mentioned in this Article  Table II. Adhesion Molecules Mentioned in this Article 
Abbreviation  Major or alternative names 
Interleukins* 
ETA-1 
IL-l~,/3 
IL-2 
IL-3 
IL-6 
IL-8 
TNF-ct 
Interferons* 
IFN-3, 
Colony-stimulating factors* 
CSF-1 
GM-CSF 
Peptide growth factors* 
EGF 
FGF 
PDGF 
TGF-a 
TGF-/3 
Early T cell activation antigen-1 
Lymphocyte-activating factor, 
endogenous pyrogen, catabolin 
T cell growth factor 
Multipotential growth factor, 
mast cell-stimulating factor 
Hepatocyte stimulating factor, 
B cell growth factor 
Neutrophil-activating peptide-  1 
Tumor necrosis factor, cachectin 
Type II or immune interferon, 
macrophage-activating factor 
Macrophage CSF 
Granulocyte/macrophage-CSF 
Epidermal growth factor 
Fibroblast growth factor 
Platelet-derived growth factor 
Transforming growth factor-u 
Transforming growth factor-/3 
* This classification  now appears arbitrary and misleading (see text). 
tion endproducts induces tumor necrosis factor (TNF)-a and 
IL-1/3 (Vlassara et al.,  1988);  adherence to serum-coated 
plastic induces PDGF-B (Shaw et al., 1990a); and adherence 
to uncoated plastic generates artefactual but powerful signals 
for induction of TNF-a, IL-1,  and CSF-1 (Eierman et al., 
1989).  Such effects may explain the influence of matrix pro- 
teins on the phenotype of macrophages in culture (Kaplan 
and Gaudernack,  1982). 
Intercellular adhesion, like adhesion of  cells to matrix, can 
also induce cytokines. Thus, binding of macrophages to tu- 
mor cells induces TNF-a (J/inicke and Mannel, 1990),  and 
binding of human monocytes to  surfaces coated with an- 
tibodies to the intercellular adhesion molecules LFA-3 or 
CIM4 (the latter is also an extracellular matrix receptor; see 
Table 1I) induces release of TNF-e~ and IL-1/3 (Webb et al., 
1990). Induction of cytokines by cell-cell interactions could 
account for the fact that some lymphocyte responses, nor- 
mally dependent on cell-cell contact, can alternatively be 
driven by exogenous cytokines. 
Cytokines Induce Cells to Alter Matrix 
TGF-~ markedly stimulates deposition of  type I collagen into 
normal rat kidney cell matrix, which may account for its abil- 
ity to inhibit growth of these cells in monolayer. Exogenous 
type I collagen mimics, and collagenase abolishes, this anti- 
proliferative action of TGF-/3 (Nugent and Newman, 1989). 
Effects of TGF-~ on collagen deposition can be ascribed, in 
part, to repression of  interstitial collagenase and the recipro- 
cal induction of tissue inhibitor of metalloproteinases (Stet- 
ler-Stevenson  et  al.,  1990);  conversely,  other  cytokines, 
such as EGF and FGF, are potent inducers of metallopro- 
teinases, which alter matrix (Edwards et al.,  1987).  IL-6 
also induces tissue inhibitor of metalloproteinases in hu- 
man chondrocytes, synoviocytes and fibroblasts (Lotz and 
Guerne,  1991). 
Designation  Alternative names/descriptions* 
Integrins 
~1/31 
~2/31 
ct3/31 
c~5/31 
ix6/31 
CD1 la/CD18 
CD1 lb/CD18 
~v/33 
gpIIb/IIIa 
Selectins 
LAM-1 
ELAM-1 
Immunoglobulin  superfamily 
LFA-3 
ICAM-1 
Class II MHC 
CD3 
Unclassified 
CD44 
VLA-1 (/31 component is CD29) 
VLA-2, CD49b/CD29, 
extracellular matrix receptor II; 
binds collagen types I, IV 
VLA-3, extracellular matrix 
receptor I; binds fibronectin, 
laminin, collagen 
VLA-5, extracellular matrix 
receptor VI; binds fibronectin 
VLA-6, CD49f/CD29; binds 
laminin 
LFA-1, uL/32 
ctM/32; complement receptor type 3 
CD51/CD61; binds vitronectin 
MIb/33,  CD41/CD61 ; binds 
fibronectin, fibrinogen, 
vitronectin, von Willebrand 
factor, thrombospondin 
Mel-14, LECCAM-1 
Endothelial-leukocyte adhesion 
molecule-l, LECCAM-2 
Lymphocyte function-associated 
antigen-3, CD58; binds CD2 
(LFA-2) 
Intercellular adhesion molecule-l, 
CD54; binds CD11a/CD18 
Major histocompatibility complex 
class II; binds T cell antigen 
receptor 
Complex of 5 constant chains of 
the T cell antigen receptor; binds 
complexes of MHC with antigen 
Phagocyte glycoprotein 1, lymph 
node homing receptor; HERMES 
antigen, extracellular matrix 
receptor M; binds hyaluronate 
* Abbreviations: CD, cluster of differentiation;  LECCAM, lectin/e_pidermal 
growth factor/complement  regulatory  protein-cell  adhesion  molecule  (referring 
to homologies of domains); LFA, lymphocyte function-associated  antigen; 
VLA, very late antigen, For review, see Springer, 1990. 
Cytokines Affect Cell Adhesion Receptors 
TGF-/3 increases  the expression of odB1,  ot2/31,  ot3~l,  and 
ol5/31  integrins  in  fibroblasts  (Heino  et  al.,  1989),  the 
CDlla/CD18  integrin in monocytic leukemia cells,  and the 
oWB3 integrin in fibroblasts and osteosarcoma cells (Ignotz 
et al.,  1989).  IL-1/3 enhances/31  integrin expression in os- 
teosarcoma  cells  (Dedhar, 1989).  IFNw  enhances  macro- 
phage binding  to laminin  (Shaw  and  Mercurio,  1989),  an 
effect that may be mediated by enhanced function of the a6~l 
integrin  associated  with  its  phosphorylation  (Shaw  et  al., 
1990b). GM-CSF and TNF-ct induce neutrophils and mono- 
cytes to shed one type of adhesion receptor,  the LAM-1  or 
MEL-14 selectin, while the cells mobilize intracellular pools 
of another type of adhesion receptor,  the/32  (CD11/CD18) 
integrins (Arnaout et al.,  1986; Griffin et al.,  1990). The/32 
integrins may act as receptors for a variety of matrix proteins 
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(Detmers et al., 1990) activate/32 integrins so as to promote 
transient attachment of neutrophils to endothelium, an effect 
distinct from increased surface expression of the integrins. 
On endothelial  cells, TNF-o~ and IL-1  induce the ELAM-1 
selectin (Bevilaqua et al.,  1989). Whether selectins can act 
as receptors for matrix proteins is not yet known. 
In  a  noteworthy  variation  on  this  theme,  the  place  of 
cytokine receptors can be taken by antigen receptors. For ex- 
ample,  engagement  of the  primary  antigen  receptor on T 
cells enhances the binding of the ~2 family integrin CD1 la/ 
CD18 (LFA-1) to its ligand, intercellular adhesion molecule-1 
(ICAM-1) (Dustin and Springer,  1990), as well as the binding 
of the/31  family integrins VLA-4, -5, and -6 to their ligands 
fibronectin and laminin  (Shimizu  et al.,  1990b).  Likewise, 
binding of superantigens,  or certain antibodies, to the class 
II MHC antigen-presenting  receptor of T cells, B cells, and 
macrophages  enhances  LFA-l-dependent  adhesion  of these 
cells (Mourad et al.,  1990). 
Matrix Presents Cytokines to Cells 
Several forms of fibroblast growth factor (FGF) (Rogelj et 
al.,  1989;  Baird  and  Bohlen,  1990),  GM-CSE  and  IL-3 
(Gordon et al.,  1987;  Roberts et al.,  1988) are among the 
cytokines that are deposited in and function when bound to 
proteoglycans of extracellular  matrix.  In contrast,  the core 
protein of the proteoglycan decorin (whose synthesis TGF-~ 
induces)  binds  and  neutralizes  TGF-/3  (Yamaguchi  et  al., 
1990). Binding of vitronectin to surfaces induces it to bind 
~-endorphin  (Hildebrand  et al.,  1989).  Differentiation  in- 
hibiting  activity/leukemia  inhibitory  factor is produced  in 
two forms by alternate usage of the first exon. One form is 
diffusible; the other binds to matrix (Rathjen et al.,  1990). 
Some Adhesion Receptors Can Act Like 
Cytokine Receptors 
Treatment of mouse macrophages with mAb to/32 integrins 
induces changes in phenotype over several days that are in- 
distinguishable from responses to IFN-3, (Ding et al., 1987). 
Fibronectin, fibronectin fragments, anti-fibronectin receptor 
mAbs, or laminin can mimic FGF, PDGF, or IL-1 by induc- 
ing some cells to become alkaline (Ingber et al., 1990), tran- 
scribe protooncogenes (Dike and Farmer,  1988), divide (re- 
viewed by Martin and Sank,  1990), and secrete collagenase 
and stromelysin (Werb et al.,  1989); presumably, these act 
through  adhesion  receptors. 
A macrophage-activating  cytokine termed Eta-1 depends 
on an RGD sequence for its interaction  with macrophages 
(Singh et al.,  1990). This is reminiscent of the dependence 
of several matrix proteins on RGD sequences for their bind- 
ing to integrins (Ruoslahti and Pierschbacher,  1986). It will 
be interesting  to determine if the Eta-1  receptor is an inte- 
grin, and if the effects of Eta-1  can be mimicked by binding 
of macrophages  to certain matrix proteins. 
Some Cytokine Receptors Can Promote 
CeU-CeU Adhesion 
EGF  receptors can promote the binding  of hematopoietic 
cells to bone marrow stromal cells expressing the transmem- 
brahe  form  of the  ligand,  pro-TGF-o~  (Anldesaria  et  al., 
1990). The cytokine remains anchored in the membrane of 
the  producer  cell,  enabling  close  interaction  with  the  re- 
sponder cell,  a process termed "juxtacrine  secretion." 
Adhesion Can Control How Cells Respond 
to Cytokines 
A  variety  of physiologic  peptides,  including  the  cytokine 
TNF-c~, act as secretagogues for neutrophils, but only if the 
neutrophils are adherent (Nathan,  1987; Luedke and Humes, 
1989) to matrix proteins (Nathan et al.,  1989) via/32 inte- 
grins  (Nathan  and  Sanchez,  1990;  Shappell  et al.,  1990; 
Richter et al.,  1990).  Likewise, the survival of embryonic 
sensory  neurons  requires  not  only  brain-derived  neuro- 
trophic factor but also laminin (Kalcheim et al.,  1987). The 
ability of ciliary neurotrophic factor to induce type-2 astro- 
cyte development depends on matrix  (Lillien et al.,  1990). 
The amount of fibronectin or collagen on the substratum dic- 
tates whether endothelial  cells will proliferate  or differen- 
tiate  in  response  to  FGF  (Ingber  and  Folkman,  1989b). 
Whether endothelial cells respond to TGF-~ by proliferating 
to form tubes resembling capillaries,  or cease to grow, like- 
wise depends on the nature of  the extracellular matrix (Madri 
et  al.,  1990).  Pretreatment  of monocytes with  IFN-7  de- 
presses the binding capacity of their receptors for comple- 
ment component C3bi (comprised of the CDllb/CD18/32 
family integrins),  but this effect is promptly reversed when 
the cells are plated on fibronectin (Wright et al.,  1986). 
In  an  important  variation  on this  theme,  similar  to that 
noted above, the place of cytokine receptors is taken by anti- 
gen  receptors.  Thus,  activation  of T  lymphocytes via the 
CD3 component of the antigen receptor is enhanced syner- 
gistically by binding of matrix proteins to/32 integrins (Car- 
terra  et  al.,  1988;  Wacholz  et  al.  1989;  Van  Seventer et 
al.,  1990), interaction with collagen (Dang et al.,  1990), or 
binding to fibronectin, laminin or vitronectin via/31 integrins 
(Nojima et al., 1990; Shimizu et al., 1990a,b; Roberts et al., 
1991).  In contrast, the matrix protein tenascin seems to in- 
hibit rather than augment the activation of T cells (Ruegg et 
al.,  1989). 
Underlying Mechanisms 
What signals from matrix induce cells to make and respond 
to cytokines? These are new questions.  To answer them is 
emerging as a major goal in cytokine and cell adhesion re- 
search.  To date,  several  mutually  compatible mechanisms 
have received experimental  support. 
(a)  Engagement  of adhesion  receptors alone by their li- 
gands or by anti-receptor  antibodies (we will refer to both 
means of  engaging receptors as "ligation') may trigger second 
messenger responses. For example, spreading of cells on fi- 
bronectin can induce intracellular alkalinization (Ingber and 
Folkman,  1989b). Lymphocytes whose CDlla/CD18  integ- 
rins are cross-linked by antibodies have responded with in- 
creases  in  intracellular  Ca  2+ and  accumulation  of inositol 
triphosphate  (Pardi et al.,  1989),  A preliminary  report in- 
volving a single time point showed a higher ratio of inositol 
mono-, di-, and tetrakis-phosphate  (but not inositol triphos- 
phate) in baby hamster kidney cells that had spread on fibro- 
nectin-coated plastic compared with those remaining rounded 
on uncoated plastic (Breuer and Wagener,  1989).  However, 
the mechanisms underlying these infrequently described re- 
sponses are far from clear. Adhesion receptors have not been 
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nase activity. 
(b) Ligation of adhesion receptors may interact synergis- 
ticaUy with ligation of cytokine receptors to induce changes 
in the levels of second messengers. To our knowledge, the 
one example reported to date involves the dependence of 
the neutrophil respiratory burst on simultaneous ligation of 
TNF-ot receptors and t2 integrins. This response is medi- 
ated, in part, by a fall in cAMP (Nathan and Sanchez, 1990). 
In experiments on platelets that did not involve cytokines, 
glycoprotein IIb/IIIa (a t3 family integrin) was required for 
epinephrine to activate phospholipases (Banga et al., 1986) 
and for thrombin to induce a subset of tyrosine phosphoryla- 
tion reactions (Ferrell and Martin,  1989).  In each of these 
examples, the biochemical basis for the interdependence of 
two distinct receptor systems remains a mystery. 
(c) Ligation of some adhesion receptors might mimic liga- 
tion of o ctokine receptors, or regulate the cellular response 
to ligation of cytokine receptors, by virtue of a physical asso- 
ciation between both types of receptors. For example, a phys- 
ical if not functional association has been demonstrated for 
intercellular adhesion molecule-1 and the IL-2 receptor (Bur- 
ton et al.,  1990). 
(d)  Complexes  formed  by  some  matrix  proteins  with 
cytokines (for example, glycosaminoglycans  with basic FGF) 
may have higher affinity  for specific receptors than do the cy- 
tokines themselves (Yayon et al.,  1991). 
(e) Alteration of cell shape by interaction with the matrix 
may activate  stretch-sensitive ion  channels,  or  transduce 
other mechanochemical signals in ways that remain to be de- 
fined (Ingber and Folkman, 1989a,b). 
(f) Interaction of cells with the extracellular matrix pro- 
motes reorganization of the cytoskeleton. The cytoskeleton 
can control the number of cytokine receptors on the plasma 
membrane (Ding et al.,  1990a), the secretion of cytokines 
(Ding et al., 1990b),  ribosome function, and gene transcrip- 
tion (reviewed in Ingber and Folkman, 1989a; Ding et al., 
1990a). 
Conclusion 
The extracellular matrix of a cell reflects its metabolic his- 
tory. As a relatively stable engram of past experiences, the 
matrix furnishes the cell with a rudimentary memory useful 
in responding appropriately to incoming stimuli. Elsewhere 
it was suggested that cytokines can be viewed as symbols in 
an intracellular language (Sporn and Roberts, 1988,  1990). 
Here we suggest that the extracellular matrix is part of the 
same language. In semantics, language itself is regarded as 
"time-binding," that is, a mechanism for recording past ex- 
perience (Korzybski, 1958).  The participation of the extra- 
cellular matrix in the language of intercellular communica- 
tion is one way that multicellular organisms can use past 
experience to help determine how their cells respond to cyto- 
kines. The amount of information potentially stored in the 
specific array of  carbohydrate moieties in the macromolecules 
of the matrix may exceed that in the genome (Rademacher 
et al., 1988). Thus, interactions with matrix enable cytokines 
to elicit adaptive responses that are rich in complexity to a 
degree not available to prokaryotes or unicellular eukaryotes. 
The physiologic target  of cytokines has  conventionally 
been regarded as the individual responding cell. We propose 
a shift in perspective, such that the targets of cytokines are 
seen as tissues. Individual ceils are seen not as targets but 
as mediators of cytokine action. In this view, cytokines are 
intercellular signaling proteins whose physiologic role is to 
coordinate the modeling and remodeling of tissues-devel- 
opmentally  programmed,  constitutive,  and  unscheduled. 
This shift in perspective leads to a corresponding shift in pre- 
dictions regarding the major determinants of  cytokine  action. 
For example, as we argue above, the effects of cytokines can 
be profoundly influenced by reciprocal interactions of re- 
sponding ceils with the extraceUular matrix. 
In homeostasis, cytokines  act vicinally in surface-bound or 
diffusible form. In pathologic states, cytokines may circulate 
to act beyond the organ of origin. A combined requirement 
for diffusible (cytokine) and nondiffusible (matrix) signals 
may be an important mechanism for localizing the responses 
of cells to a cytokine that is widely distributed. Similarly, the 
ability of matrix to present cytokines in either an active or 
inactive form may contribute to the spatial control that a tis- 
sue can exert over the cytokine responses of cells within it. 
Finally, the ability to produce a cytokine either in diffusible, 
cell surface-bound, or matrix-bound forms may give a cell 
some control over that cytokine's sphere of  influence (Rathjen 
et al., 1990).  Since matrix can present cytokines, and since 
binding of ceils to matrix proteins can both induce cytokines 
and synergize with them, it is possible that the apparent in- 
duction of cell differentiation by matrix proteins alone (Ing- 
ber and Folkman, 1989a,b; Grant et al.,  1989) may some- 
times result from the combined action of  matrix proteins with 
cytokines acting in an autocrine or paracrine manner. Thus, 
combined control of cell function by matrix proteins and cy- 
tokines may be a widespread phenomenon. 
A shift in emphasis from the actions of cytokines on indi- 
vidual cells to their actions on tissues raises the difficult  prob- 
lem of how to study cytokine actions in vitro. Experiments 
with isolated cell populations exposed to cytokines in vitro 
have led to the description of countless, often contradictory 
bioactivities, among which it is difficult to discern those of 
physiologic and pathophysiologic relevance. Ad hoc criteria 
include the magnitude of a given effect and the potency with 
which it is induced, its robustness as experimental conditions 
are varied (reflected in the ease of its confirmation), and the 
existence of countereffects that can be construed as regula- 
tory. However,  definitive evidence for the physiologic rele- 
vance of a given action of a cytokine requires tests in intact 
organisms. Here, the cardinal criterion is the association of 
natural or induced states of cytokine deficiency with patho- 
logic effects, and the reversal of these effects with cytokine 
repletion (e.g., Nathan et al., 1986;  Kodama et al.,  1991). 
A secondary criterion is the association of natural or induced 
states of cytokine excess with therapeutic or pathologic ef- 
fects, and their correction with depletion. Obviously, such 
tests are difficult to carry out. A major practical problem is 
how to conduct tests of cytokine action in vitro that can best 
inform the design of studies in vivo, if not predict their out- 
come. Perhaps experiments with cytokines in vitro will yield 
physiologically more relevant information as investigators 
take increasingly into account the extracellular milieu of the 
responding ceils. 
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